BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 1705185)

  • 1. Glyceryl ethers in peroxisomal disease.
    Poulos A; Bankier A; Beckman K; Johnson D; Robertson EF; Sharp P; Sheffield L; Singh H; Usher S; Wise G
    Clin Genet; 1991 Jan; 39(1):13-25. PubMed ID: 1705185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of three distinct peroxisomal protein import defects in patients with peroxisome biogenesis disorders.
    Slawecki ML; Dodt G; Steinberg S; Moser AB; Moser HW; Gould SJ
    J Cell Sci; 1995 May; 108 ( Pt 5)():1817-29. PubMed ID: 7544797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberration in de novo ether lipid biosynthesis in peroxisomal disorders.
    van den Bosch H; Schalkwijk CG; Schrakamp G; Wanders RJ; Schutgens RB; Schram AW; Tager JM
    Prog Clin Biol Res; 1988; 282():139-50. PubMed ID: 3071794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical abnormalities in rhizomelic chondrodysplasia punctata.
    Hoefler G; Hoefler S; Watkins PA; Chen WW; Moser A; Baldwin V; McGillivary B; Charrow J; Friedman JM; Rutledge L
    J Pediatr; 1988 May; 112(5):726-33. PubMed ID: 2452243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phytanic acid alpha-oxidation and complementation analysis of classical Refsum and peroxisomal disorders.
    Poll-The BT; Skjeldal OH; Stokke O; Poulos A; Demaugre F; Saudubray JM
    Hum Genet; 1989 Jan; 81(2):175-81. PubMed ID: 2463966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmalogen biosynthesis in peroxisomal disorders: fatty alcohol versus alkylglycerol precursors.
    Schrakamp G; Schalkwijk CG; Schutgens RB; Wanders RJ; Tager JM; van den Bosch H
    J Lipid Res; 1988 Mar; 29(3):325-34. PubMed ID: 3379344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polarizing inclusions in some organs of children with congenital peroxisomal diseases (Zellweger's, Refsum's, chondrodysplasia punctata (rhizomelic form), X-linked adrenoleukodystrophy).
    Kerckaert I; Dingemans KP; Heymans HS; Vamecq J; Roels F
    J Inherit Metab Dis; 1988; 11(4):372-86. PubMed ID: 2468818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal profiles of polyunsaturated fatty acids in the brain, liver, kidney and retina of patients with peroxisomal disorders.
    Martinez M
    Brain Res; 1992 Jun; 583(1-2):171-82. PubMed ID: 1504825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation of a novel arachidonic acid metabolite in peroxisomes.
    Gordon JA; Heller SK; Rhead WJ; Watkins PA; Spector AA
    Prostaglandins Leukot Essent Fatty Acids; 1995; 52(2-3):77-81. PubMed ID: 7540307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisomal integral membrane proteins in livers of patients with Zellweger syndrome, infantile Refsum's disease and X-linked adrenoleukodystrophy.
    Small GM; Santos MJ; Imanaka T; Poulos A; Danks DM; Moser HW; Lazarow PB
    J Inherit Metab Dis; 1988; 11(4):358-71. PubMed ID: 2468817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Zellweger syndrome, neonatal adrenoleukodystrophy or infantile Refsum's disease in a case with generalized peroxisome defect?].
    Schmitt K; Molzer B; Stöckler S; Tulzer G; Tulzer W
    Wien Klin Wochenschr; 1993; 105(11):320-2. PubMed ID: 7687405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic diseases caused by peroxisomal dysfunction. New findings in clinical and biochemical studies.
    Schutgens RB; Wanders RJ; Nijenhuis A; van den Hoek CM; Heymans HS; Schrakamp G; Bleeker-Wagemakers EM; Delleman JW; Schram AW; Tager JM
    Enzyme; 1987; 38(1-4):161-76. PubMed ID: 3440444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. More on Zellweger's syndrome, infantile Refsum's disease, and rhizomelic chondrodysplasia punctata.
    Goldfischer SL
    N Engl J Med; 1986 Sep; 315(12):766-7. PubMed ID: 2427949
    [No Abstract]   [Full Text] [Related]  

  • 14. Accumulation and defective beta-oxidation of very long chain fatty acids in Zellweger's syndrome, adrenoleukodystrophy and Refsum's disease variants.
    Poulos A; Singh H; Paton B; Sharp P; Derwas N
    Clin Genet; 1986 May; 29(5):397-408. PubMed ID: 2427264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisomal disorders. Neurodevelopmental and biochemical aspects.
    Brown FR; Voigt R; Singh AK; Singh I
    Am J Dis Child; 1993 Jun; 147(6):617-26. PubMed ID: 7685145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisomal disorders.
    Moser HW; Bergin A; Cornblath D
    Biochem Cell Biol; 1991 Jul; 69(7):463-74. PubMed ID: 1724376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma polyenoic very-long-chain fatty acids in peroxisomal disease: biochemical discrimination of Zellweger's syndrome from other phenotypes.
    Poulos A; Sharp P; Johnson D
    Neurology; 1989 Jan; 39(1):44-7. PubMed ID: 2462697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular species of phosphatidylcholine containing very long chain fatty acids in human brain: enrichment in X-linked adrenoleukodystrophy brain and diseases of peroxisome biogenesis brain.
    Sharp P; Johnson D; Poulos A
    J Neurochem; 1991 Jan; 56(1):30-7. PubMed ID: 1702833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of branched chain fatty acids in peroxisomal disorders.
    Singh H; Usher S; Johnson D; Poulos A
    J Inherit Metab Dis; 1990; 13(3):387-9. PubMed ID: 1700192
    [No Abstract]   [Full Text] [Related]  

  • 20. [Peroxisomal neurologic diseases and Refsum disease: very long chain fatty acids and phytanic acid as diagnostic markers].
    Molzer B; Stöckler S; Bernheimer H
    Wien Klin Wochenschr; 1992; 104(21):665-70. PubMed ID: 1282286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.